KURSSIT JA MARKKINAT / UUTISET
Notice to the Annual General Meeting of Orion Corporation
05.02.2020 klo 12:15 Notice to the Annual General Meeting of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE 5 FEBRUARY 2020 at 12:15 EET
Notice to the Annual General Meeting of Orion Corporation
Notice is given to the shareholders of Orion Corporation to the Annual General Meeting to be held on Wednesday 25 March 2020 at 2:00 p.m. Finnish time in Messukeskus Helsinki, Exhibition and Convention Centre, address: Messuaukio 1, Helsinki. The reception of the participants and the distribution of the voting tickets will start at 1:00 p.m. Coffee will be served after the meeting.
A. Agenda of the Meeting, in the order of handling
1. Opening of the Meeting
2. Matters of order for the Meeting
3. Election of the person to confirm the minutes and the persons to verify the counting of votes
4. Recording the legal convening of the Meeting and quorum
5. Recording the attendance at the Meeting and the list of votes
6. Presentation of the Financial Statements 2019, the report of the Board of Directors and the Auditor’s report
·Review by the President and CEO
7. Adoption of the Financial Statements
8. Decision on the use of the profits shown on the Balance Sheet and the payment of the dividend
The Board of Directors proposes that a dividend of EUR 1.50 per share be paid on the basis of the Balance Sheet confirmed for the financial year that ended on 31 December 2019. According to the proposal, the dividend is paid to Orion Corporation shareholders entered in the Company’s register of shareholders maintained by Euroclear Finland Ltd on the record date of the dividend distribution, 27 March 2020. The date of the dividend payment is 3 April 2020.
9. Decision on the discharge of the members of the Board of Directors and the President and CEO from liability
10. Handling of the remuneration policy for governing bodies
Handling of the remuneration policy for governing bodies approved by the Board of Directors.
11. Decision on the remuneration of the members of the Board of Directors
The Company's Nomination Committee has announced as its recommendation that the
following remunerations will remain the same as in the previous year and be paid to the Board of Directors:
As an annual fee, the Chairman would receive EUR 84,000, the Vice Chairman would receive EUR 55,000 and the other members would receive EUR 42,000 each.
As a fee for each meeting attended, the Chairman would receive EUR 1,200, the Vice Chairman would receive EUR 900 and the other members would receive EUR 600 each. The travel expenses of the Board members would be paid in accordance with the previously adopted practice. The aforementioned fees would also be paid to the Chairmen and to the members of the committees established by the Board, for each committee meeting attended.
Of the above-mentioned annual fees, 60% would be paid in cash and 40% in Orion Corporation B-shares, which would be acquired for the members over the period 29 April–6 May 2020 from the stock exchange in amounts corresponding to EUR 33,600 for the Chairman, EUR 22,000 for the Vice Chairman and EUR 16,800 for each of the other members. The part of the annual fee that is to be paid in cash corresponds to the approximate sum necessary for the payment of the income taxes on the fees and would be paid no later than 29 May 2020. The annual fees shall encompass the full term of office of the Board of Directors.
In addition, the Company would pay the transfer tax related to the part of the annual fee of the Board of Directors paid in shares.
The Nomination Committee has not given its recommendation for the remunerations to the Board of Directors, but the matter will be proposed by a shareholder at the Annual General Meeting.
12. Decision on the number of members of the Board of Directors
In accordance with the recommendation by the Company's Nomination Committee, the
Board of Directors proposes to the Annual General Meeting that the number of the
members of the Board of Directors be seven.
13. Election of the members and the Chairman of the Board of Directors
In accordance with the recommendation by the Nomination Committee, the Board of Directors proposes to the Annual General Meeting that of the present members of the Board, Pia Kalsta, Ari Lehtoranta, Timo Maasilta, Hilpi Rautelin, Eija Ronkainen and Mikael Silvennoinen would be re-elected for the next term of office and M.Sc. (Econ. and Bus. Adm.) Kari Jussi Aho would be elected as a new member.
Mikael Silvennoinen would be elected as Chairman of the Board.
All proposed members have been assessed to be independent of the Company and its significant shareholders.
Of the present members, Heikki Westerlund has been a Board member for an uninterrupted period of 10 years and for this reason he is not proposed for re-election.
Mikael Silvennoinen has been a member of the Orion Board of Directors since 2014 and currently he is also the Chairman of the Audit Committee and a member of the Remuneration Committee and the R&D Committee. He holds a Master of Science degree in Economics and his principal occupation is Executive Chairman of IMS Talent Oy. More detailed information on Mikael Silvennoinen is available on Orion website at http://www.orion.fi/en.
Personal information of Kari Jussi Aho:
Education and profession: MSc (Econ. and Bus. Adm.), MBA, business owner and entrepreneur
Key work experience:Business owner and entrepreneur, 2020-Rukakeskus Group, full-time Chairman of the Board, 2004-2019Pyhätunturi Ltd, Managing Director, 1987-2004Rukakeskus Ltd, Marketing Manager, 1982-2002
Current key positions of trust:
Vice Chairman of the Board: Confederation of Finnish Industries EK 2017-, Finnish Air Force support foundation (Non-profit foundation) 2010-
Member of the Board: Aho Group Ltd 2006-, Aava Health Services Ltd 2016-, Economy and Youth TAT 2017-
Other: Confederation of Finnish Industries EK, Delegation for Entrepreneurs, Chairman 2017-, Confederation of Finnish Industries EK, Suomalaisen omistajuuden työryhmä (working group for Finnish ownership), Chairman 2017-
Previous key positions of trust:
Chairman of the Board: Aho Group Ltd 2006-2012
Vice Chairman of the Board: United Laboratories Ltd 2004-2009
Member of the Board: Cor Group Ltd 2007-2011, Haaga-Helia Ltd 2009-2014, Management Institute of Finland MIF Ltd 2012-2014
Member of the Supervisory Board: Orion Corporation 2001-2002
Member of the Nomination Committee: Orion Corporation 2006-2019
14. Decision on the remuneration of the Auditor
In accordance with the recommendation by the Board's Audit Committee, the Board of
Directors proposes to the Annual General Meeting that the remunerations to the Auditor be paid on the basis of invoicing approved by the Company.
15. Election of the Auditor
In accordance with the recommendation by the Board's Audit Committee, the Board of
Directors proposes to the Annual General Meeting that Authorised Public Accountants KPMG Oy Ab be elected as the Company's Auditor.
16. Forfeiture of shares in Orion Corporation on joint account
The shares in the predecessor of the current Orion Corporation, Orion-yhtymä Oy (Business ID 0112283-5, as of 11 December 1997 Orion-yhtymä Oyj), were incorporated in the book-entry system in 1993. The shareholders were at that time required to declare their shares for registration on their book-entry account, in practice meaning exchanging paper share certificates for registrations on a book-entry account, at the latest on the registration date 29 October 1993. Those shares that had not been registered on a shareholder’s book-entry account at the latest on the registration date were registered on a joint account opened in the book-entry system, where they have been stored on behalf of the shareholders.
Orion-yhtymä Oyj has later changed its name to Orion Corporation and on 1 July 2006 demerged into two companies, the current Orion Corporation (Business ID 1999212-6, hereinafter “Orion”) and Oriola-KD Corporation (Business ID 1999215-0, currently Oriola Corporation, hereinafter “Oriola”). In the demerger, the shareholders of the old Orion Corporation received as demerger consideration one share in each of the current Orion and Oriola per each share in the old Orion Corporation. The owners of paper share certificates were required to declare their ownership for registration in the book-entry system before the effective date of the demerger to avoid the shares to be given to them as demerger consideration being registered on a joint account. A shareholder has been able to transfer their shares from the joint account to their book-entry account by making a declaration for registration.
A joint account is intended for temporary storing of shares until the shareholders declare their shares for registration on their personal book-entry account, and the rights of a shareholder (inter alia, to receive dividend) cannot be exercised until the shares have been registered on the shareholder’s book-entry account. A number of shares in Orion are nevertheless still registered on the joint account because the owners of such shares have not after the incorporation of the shares in the book-entry system in 1993 made a declaration for registration.
Orion’s predecessor Orion-yhtymä Oy carried out in 1993 a share issue without payment (bonus issue) where shareholders were entitled to subscribe for new shares in Orion-yhtymä Oy free of charge so that five old Class A shares yielded two new Class A shares and five old Class B shares yielded two new Class B shares. As a result of the 1993 bonus issue, the shares corresponding to the subscription rights issued in the bonus issue with respect to which the shareholder did not use their subscription rights in connection with the bonus issue were registered on the joint account. Such shares in Orion are still registered on the joint account. The subscription rights in the 1993 bonus issue registered on a shareholder’s book-entry account still entitle to subscription of shares in the current Orion, and the due to the subscription ratio, the subscription rights can be used to subscribe for shares when there are at least five subscription rights.
The shares registered on Orion’s joint account as at 27 January 2020, a total of 125,674 shares (64,478 Class A shares and 61,196 Class B shares), correspond to approximately 0.09% of the Company’s total shares.
Pursuant to provisions included in the Finnish company legislation in 2006, it has after the lapse of a transition period of ten years been possible for Orion’s Annual General Meeting to resolve that shareholders forfeit their rights to the shares on the joint account and to the rights that such shares carry.
Due to the aforementioned, the Board of Directors proposes that the Annual General Meeting resolve pursuant to chapter 3, section 14 a, subsection 3 and chapter 9, section 19 of the Companies Act that the right to shares in Orion and to the rights such shares carry be forfeited with respect to all shares regarding which a declaration for registration to a book-entry account and, with respect to any declaration for registration based on the incorporation in the book-entry system, also the share certificate or other reliable evidence of title, has not been presented to Orion at the latest on 25 March 2020.
To the extent the declaration for registration is based on the incorporation in the book-entry system and the share certificate or other corresponding document has been lost, the declaration for registration must be made at the latest on the aforementioned date and the ruling on the cancellation of the share certificate or other corresponding document must be presented to Orion at the latest on 30 November 2020.
The shares that are subject to the forfeiture become Orion’s property, and the provisions on treasury shares apply to such shares.
More detailed instructions are presented on Orion’s website https://www.orion.fi/en/Orion-group/investors/messages-to-shareholders/joint-account-shares/ for those shareholders who have not previously made a declaration for the registration of the shares on their book-entry accounts based on the incorporation in the book-entry system or based on the exercise of the subscription rights registered on the shareholder’s book-entry account, and who wish to make a declaration for the registration of their rights to the shares in the book-entry system and for the transfer of the number of shares equivalent to their shareholding from the joint account to the shareholder’s own book-entry account within the above deadlines.
The possible resolution of Orion’s Annual General Meeting on the forfeiture of the shares on the joint account and of the rights that such shares carry only concerns the shares in Orion. The corresponding rights in Oriola’s shares and any possible forfeitures related to them are determined in accordance with resolutions possibly made by Oriola.
17. Closing of the Meeting
B. Documents of the Annual General Meeting
The unofficial English versions of the proposals of the Board of Directors, of the
recommendation of the Nomination Committee, of the remuneration policy for governing bodies as well as this Notice to the Annual General Meeting are available on the website of Orion Corporation, at www.orion.fi. The Financial Statement documents of Orion Corporation, which include the Financial Statements, the Report of the Board of Directors and the Auditor’s Report, will be available on the above-mentioned website no later than 4 March 2020. The aforementioned documents will also be available at the Annual General Meeting.
C. Instructions for the participants in the Annual General Meeting
1.The right to participate and registration
Shareholders being registered in the Company’s register of shareholders, maintained by Euroclear Finland Ltd, on 13 March 2020 have the right to attend the Annual General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the Company’s register of shareholders. Changes in the holding of shares that take place after the record date of the Annual General Meeting do not affect on the shareholder’s right to participate in the Annual General Meeting or the number of the shareholder’s votes.
A shareholder, who intends to participate in the Annual General Meeting, shall register for the Meeting by giving a prior notice of participation to the Company no later than 19 March 2020 at 4:00 p.m. Finnish time. The notice can be given in either of the following ways:Electronically through Internet, at www.orion.fi/en By telephone to +358 20 770 6906 (Monday–Friday 9:00 a.m. – 4:00 p.m.)By letter to Orion Corporation, Treasury, P.O.Box 65, FI-02101 Espoo, Finland.
In the registration, a shareholder shall notify his/her name, personal identification code or the company code, address, phone number and the name and the personal identification of a possible assistant or proxy representative. The personal registering details submitted to Orion Corporation will only be used in connection with the Annual General Meeting and necessary registrations relating to it. A shareholder, his/her representative or proxy representative shall, on demand, be able to prove their identity and/or right to representation at the venue.
2. Holders of nominee-registered shares
A holder of nominee registered shares has the right to participate in the Annual General Meeting on the basis of those shares as would entitle him/her to be registered in the shareholder register maintained by Euroclear Finland Ltd on the record date of the Annual General Meeting, 13 March 2020. Additionally, the holder of those shares is requested to be temporarily entered in the shareholder register maintained by Euroclear Finland Ltd no later than 20 March 2020 at 10:00 a.m. Finnish time. For nominee registered shares, this constitutes due registration for the Annual General Meeting.
A holder of nominee registered shares is advised to request early enough the necessary instructions concerning the temporary registration in the Company’s register of shareholders, the issuing of proxy documents and the registration for the Annual General Meeting from his/her custodian bank. The holder of nominee registered shares who aims to participate in the Annual General Meeting, must be temporarily entered by the account operator of the custodian bank in the Company’s register of shareholders no later than the above-mentioned time.
3. Proxy representation and powers of attorney
A shareholder may participate in the Annual General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall present a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the Meeting. If a shareholder attends the Meeting by way of several proxy holders representing the shareholder with shares entered in different security accounts, the shares represented by each proxy holder must be identified when registering for the Annual General Meeting.
Possible proxies are requested to be delivered to Orion Corporation, Treasury, P.O.Box 65, FI-02101 Espoo, Finland, or to the e-mail address email@example.com before the end of the registration period.
4. Other information
Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the Annual General Meeting has the right to request information on the matters dealt with at the Meeting.
On 5 February 2020, the date of the Notice to the Annual General Meeting, the total number of shares in Orion Corporation is 141,257,828, of which 36,107,240 are Class A shares and 105,150,588 Class B shares. The total number of votes is 827,295,388, of which Class A shares account for 722,144,800 votes and Class B shares for 105,150,588 votes.
Espoo, 5 February 2020
Board of Directors
President and CEO Olli Huotari
SVP, Corporate Functions
Timo Lappalainen, President and CEO, phone +358 10 426 3692
Olli Huotari, Senior VP, Corporate Functions, Secretary of the Board of Directors, phone +358 50 966 3054
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion's net sales in 2019 amounted to EUR 1,051 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
AttachmentOrion Corporation Remuneration Policy